EcoR1 Capital, LLC 13D and 13G filings for Atea Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 12:47 pm Sale | 2024-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR | EcoR1 Capital, LLC | 3,341,653 4.000% | -2,100,243 (-38.59%) | Filing |
| 2024-11-15 10:34 am Sale | 2024-09-30 | 13G | Atea Pharmaceuticals, Inc. AVIR | EcoR1 Capital, LLC | 5,441,896 6.400% | -1,553,965 (-22.21%) | Filing |
| 2024-02-15 11:35 am Unchanged | 2023-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR | EcoR1 Capital, LLC | 6,995,861 8.400% | 0 (Unchanged) | Filing |
| 2024-02-15 09:15 am Unchanged | 2023-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR | EcoR1 Capital, LLC | 6,995,861 8.400% | 0 (Unchanged) | Filing |
| 2024-02-14 8:02 pm Purchase | 2023-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR | EcoR1 Capital, LLC | 6,995,861 8.400% | 811,000 (+13.11%) | Filing |
| 2023-02-10 1:37 pm Purchase | 2022-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR | EcoR1 Capital, LLC | 6,184,861 7.400% | 808,727 (+15.04%) | Filing |
| 2021-12-10 5:08 pm Purchase | 2021-12-01 | 13G | Atea Pharmaceuticals, Inc. AVIR | EcoR1 Capital, LLC | 5,376,134 6.500% | 5,376,134 (New Position) | Filing |